ClinicalTrials.gg
Sign In

Multiple Myeloma clinical trials

The registry lists 3,760 studies for Multiple Myeloma across more than 10 countries. 769 are recruiting or about to start. 2,824 of them are mainly about Multiple Myeloma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Leukemia, Plasma Cell too: 3,773 studies, 775 open.

ClinicalTrials.gov finds 4,059 studies for Multiple Myeloma. How that becomes 3,758 here

This page counts the studies the registry files under Multiple Myeloma, and those it files under no condition that list Multiple Myelomathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 4,059Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −12Filed under a narrower condition, counted on its own pageLeukemia, Plasma Cell 11
  3. −59List Multiple Myeloma as a condition, but the registry did not file them under itMost often written as “Smoldering Multiple Myeloma” (30), “Smoldering Plasma Cell Myeloma” (10), and “Multiple Myeloma in Relapse” (3). The registry filed 2 of them under no condition at all, and the others under other conditions only, most often Smoldering Multiple Myeloma (44) and Monoclonal Gammopathy of Undetermined Significance (11).
  4. −230Match it another way82 name it in the title, 2 in a keyword, and 146 by a synonym or other text the search reads.
  5. 3,758The count on this page88 of them list Multiple Myeloma in their own words; the registry filed them under no condition.

Get an email when these change. Save the Multiple Myeloma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
1,707
Recruiting
584
Terminated
494
Active, not recruiting
328
Status unknown
279
Not yet recruiting
171

Phase

Phase 2
1,619
Phase 1
1,221
Phase 3
397
Early Phase 1
89
Phase 4
57

Where

United States
2,167
China
447
France
376
Spain
315
Germany
297
Italy
287

Who runs them

National Cancer Institute (NCI) (140) · Celgene (92) · Mayo Clinic (84) · Memorial Sloan Kettering Cancer Center (78) · Fred Hutchinson Cancer Center (72) · M.D. Anderson Cancer Center (67) · Janssen Research & Development, LLC (66) · University of Arkansas (55)

What is being tested here

Drugs under test in Multiple Myeloma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexamethasone4055366
Lenalidomide2743241
Teclistamab22931
Elranatamab22531
Daratumumab2124129
Talquetamab20627
Pomalidomide151799
Belantamab mafodotin15948
Cyclophosphamide1415169
Isatuximab14948

Drug classes tested here Corticosteroids 44 open · Proteasome inhibitors 24 open · Alkylating agents 19 open · Antibody-drug conjugates (ADCs) 16 open · Antimetabolites 6 open

Coming up

128phase 3 studies under way
309studies finish main data collection within a year24 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 584 Multiple Myeloma studies recruiting now, 429 (73%) set no upper age limit and 106 (18%) stop at 75 or younger. 36 (6%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 24 (4%) take healthy volunteers.

Recruiting studies that take each age, of 584
AgeWomenMen
1029 (5%)29 (5%)
18545 (93%)545 (93%)
30560 (96%)560 (96%)
40562 (96%)562 (96%)
50565 (97%)565 (97%)
65576 (99%)576 (99%)
75545 (93%)545 (93%)
85456 (78%)456 (78%)

Across all 3,760 studies, recruiting or not: 21% stop at 75 or younger and 6% at 65; 10% take children; <1% are for women only and <1% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Multiple Myeloma studies take

Of 505 phase 2 interventional studies under Multiple Myeloma, half reached primary completion within 57 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 150 mo33–75 · 413 studies43 mo27–71 · 212 studies57 mo39–99 · 201 studies
Phase 1/265 mo44–92 · 201 studies64 mo42–90 · 98 studies67 mo46–94 · 103 studies
Phase 257 mo35–95 · 505 studies38 mo27–77 · 93 studies59 mo40–96 · 412 studies
Phase 356 mo35–95 · 178 studies45 mo31–66 · 107 studies87 mo48–108 · 71 studies
Phase 442 mo30–57 · 28 studies——
Interventional, no phase38 mo20–79 · 186 studies—37 mo21–81 · 172 studies
Observational61 mo30–126 · 239 studies49 mo28–70 · 66 studies70 mo33–… · 173 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting8

Show 3 more

Results posted3

Stopped2

Newly registered20

Show 15 more

Studies

Recruiting first, then most recently updated. Showing 50 of 3,760. Browse all 3,760 → or search them.